HDC
Basic information
Region (hg38): 15:50241947-50265965
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (Limited), mode of inheritance: Unknown
- Tourette syndrome (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Tourette's syndrome | AD | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Neurologic | 20445167 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HDC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 6 | |||||
missense | 31 | 37 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 1 | 31 | 8 | 4 |
Variants in HDC
This is a list of pathogenic ClinVar variants found in the HDC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-50242303-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
15-50242474-A-G | not specified | Uncertain significance (Dec 14, 2021) | ||
15-50242478-G-A | not specified | Uncertain significance (Nov 22, 2021) | ||
15-50242506-C-T | Benign (Dec 31, 2019) | |||
15-50242520-T-A | not specified | Uncertain significance (Dec 21, 2021) | ||
15-50242574-C-T | not specified | Uncertain significance (Apr 06, 2022) | ||
15-50242592-A-G | Benign (Dec 31, 2019) | |||
15-50242635-A-G | HDC-related disorder | Benign (Oct 28, 2019) | ||
15-50242666-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
15-50242681-A-T | Tourette syndrome | Uncertain significance (Sep 28, 2020) | ||
15-50242693-G-C | not specified | Uncertain significance (Mar 14, 2023) | ||
15-50242694-C-A | not specified | Uncertain significance (Jun 21, 2023) | ||
15-50242721-T-C | not specified | Uncertain significance (May 07, 2024) | ||
15-50242725-A-G | HDC-related disorder | Likely benign (May 02, 2019) | ||
15-50242738-G-A | not specified | Likely benign (Feb 05, 2024) | ||
15-50242738-G-T | Tourette syndrome | Uncertain significance (Jan 09, 2018) | ||
15-50242769-T-C | Benign/Likely benign (Mar 01, 2022) | |||
15-50242793-G-A | not specified | Uncertain significance (Apr 06, 2023) | ||
15-50242811-T-C | not specified | Uncertain significance (Dec 14, 2021) | ||
15-50243151-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
15-50243197-A-G | not specified | Likely benign (Apr 11, 2024) | ||
15-50248252-A-C | Tourette syndrome | Uncertain significance (Mar 25, 2024) | ||
15-50248307-C-G | not specified | Uncertain significance (Jan 10, 2023) | ||
15-50252520-C-T | Tourette syndrome | Pathogenic (Jan 08, 2014) | ||
15-50252673-C-T | not specified | Uncertain significance (Feb 21, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HDC | protein_coding | protein_coding | ENST00000267845 | 12 | 24080 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00411 | 0.996 | 125729 | 0 | 19 | 125748 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.04 | 312 | 368 | 0.848 | 0.0000216 | 4359 |
Missense in Polyphen | 100 | 158.66 | 0.63026 | 1907 | ||
Synonymous | -0.849 | 157 | 144 | 1.09 | 0.00000866 | 1318 |
Loss of Function | 3.49 | 10 | 31.0 | 0.323 | 0.00000189 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000173 | 0.000173 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000881 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the biosynthesis of histamine from histidine. {ECO:0000269|PubMed:22767596}.;
- Pathway
- Histidine metabolism - Homo sapiens (human);Histidine Metabolism;Histidinemia;Amino Acid metabolism;Biogenic Amine Synthesis;Histidine catabolism;Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism;Metabolism of amino acids and derivatives;Metabolism;histamine biosynthesis;Histidine degradation
(Consensus)
Recessive Scores
- pRec
- 0.256
Intolerance Scores
- loftool
- 0.409
- rvis_EVS
- -0.24
- rvis_percentile_EVS
- 36.17
Haploinsufficiency Scores
- pHI
- 0.191
- hipred
- Y
- hipred_score
- 0.554
- ghis
- 0.400
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.960
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hdc
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; immune system phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- hdc
- Affected structure
- brain
- Phenotype tag
- abnormal
- Phenotype quality
- morphology
Gene ontology
- Biological process
- histamine biosynthetic process;histidine metabolic process;histidine catabolic process;catecholamine biosynthetic process
- Cellular component
- cytosol
- Molecular function
- histidine decarboxylase activity;protein binding;pyridoxal phosphate binding